The difference between a promising therapy and a transformative one often comes down to delivery. Continuity Biosciences builds precision delivery platforms that close the gap between what a therapy can do and what a patient actually experiences. Our adaptive, therapy-agnostic technologies support applications across oncology, chronic disease, and medical aesthetics, spanning small molecules, biologics, and cell-based therapies. We don't build around a single drug or indication. We build infrastructure for better therapeutic delivery, wherever it matters most. Our science is rooted in research from Houston Methodist, University of Miami, University of North Carolina. Our collective work spans 135 publications and 80 patents—not as a measure of the past, but as a foundation for what comes next. We welcome conversations with partners, investors, and collaborators. Reach out or follow along as we build.
我們正在追蹤 Continuity Biosciences, LLC 的市場擴張
Continuity Biosciences, LLC 的國際擴張與競爭對手的比較
Continuity Biosciences, LLC你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Continuity Biosciences, LLC你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
Continuity Biosciences啟動第一期胰腺癌臨床試驗,使用離子電滲平台直接向腫瘤輸送吉西他濱,在西維吉尼亞大學和密歇根大學醫學中心招募患者。
Continuity Biosciences在WVU Medicine和密歇根大學等主要學術中心啟動第一期試驗,評估通過IOP平台輸送吉西他濱治療胰臟癌。
Continuity Biosciences 在頂尖學術醫療中心啟動首次人體第一階段臨床試驗,評估透過其離子電滲腫瘤平台輸送吉西他濱治療胰臟癌。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Continuity Biosciences, LLC 業務、市場及增長訊號的快速解答。
